{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T03:14:59Z","timestamp":1774408499612,"version":"3.50.1"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2017,2,6]],"date-time":"2017-02-06T00:00:00Z","timestamp":1486339200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2017,2,6]],"date-time":"2017-02-06T00:00:00Z","timestamp":1486339200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1007\/s10067-017-3568-y","type":"journal-article","created":{"date-parts":[[2017,2,6]],"date-time":"2017-02-06T15:47:02Z","timestamp":1486396022000},"page":"729-733","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Multicentric Castleman\u2019s disease associated with IgA vasculitis (Henoch-Sch\u00f6nlein purpura) responding well to tocilizumab: a case report"],"prefix":"10.1007","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1908-6329","authenticated-orcid":false,"given":"Yoichi","family":"Oshima","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junichi","family":"Hoshino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuya","family":"Suwabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noriko","family":"Hayami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masayuki","family":"Yamanouchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akinari","family":"Sekine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiharu","family":"Ueno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroki","family":"Mizuno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junko","family":"Yabuuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aya","family":"Imafuku","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Kawada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rikako","family":"Hiramatsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eiko","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Sawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenmei","family":"Takaichi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobukazu","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Fujii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshifumi","family":"Ubara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,2,6]]},"reference":[{"key":"3568_CR1","doi-asserted-by":"publisher","unstructured":"Castleman B, Towne V (1954) Case records of the massachusetts general hospital weekly clinicopathological exercises: Case 40011. N Engl J Med 250(1):26\u201330. doi:10.1056\/nejm195401072500107","DOI":"10.1056\/nejm195401072500107"},{"issue":"4","key":"3568_CR2","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1002\/1097-0142(195607\/08)9:4<822::AID-CNCR2820090430>3.0.CO;2-4","volume":"9","author":"B Castleman","year":"1956","unstructured":"Castleman B, Iverson L, Menendez VP (1956) Localized mediastinal lymphnode hyperplasia resembling thymoma. Cancer 9(4):822\u2013830","journal-title":"Cancer"},{"issue":"3","key":"3568_CR3","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1053\/j.sult.2013.12.005","volume":"35","author":"D Bonekamp","year":"2014","unstructured":"Bonekamp D, Hruban RH, Fishman EK (2014) The great mimickers: Castleman disease. Semin Ultrasound CT MR 35(3):263\u2013271. doi:10.1053\/j.sult.2013.12.005","journal-title":"Semin Ultrasound CT MR"},{"issue":"11","key":"3568_CR4","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1002\/ajh.23291","volume":"87","author":"A Dispenzieri","year":"2012","unstructured":"Dispenzieri A, Armitage JO, Loe MJ, Geyer SM, Allred J, Camoriano JK, Menke DM, Weisenburger DD, Ristow K, Dogan A, Habermann TM (2012) The clinical spectrum of castleman\u2019s disease. Am J Hematol 87(11):997\u20131002. doi:10.1002\/ajh.23291","journal-title":"Am J Hematol"},{"issue":"Suppl 2","key":"3568_CR5","doi-asserted-by":"publisher","first-page":"S169","DOI":"10.5021\/ad.2011.23.S2.S169","volume":"23","author":"HY Park","year":"2011","unstructured":"Park HY, Lee JJ, Lee JB, Kim SJ, Lee SC, Won YH, Yun SJ (2011) Castleman\u2019s disease with cutaneous involvement manifestating as multiple violaceous plaques on entire body. Ann Dermatol 23(Suppl 2):S169\u2013S174. doi:10.5021\/ad.2011.23.S2.S169","journal-title":"Ann Dermatol"},{"issue":"8","key":"3568_CR6","doi-asserted-by":"publisher","first-page":"e754","DOI":"10.1111\/j.1365-2230.2009.03479.x","volume":"34","author":"HL Tey","year":"2009","unstructured":"Tey HL, Tang MB (2009) A case of paraneoplastic pemphigus associated with Castleman\u2019s disease presenting as erosive lichen planus. Clin Exp Dermatol 34(8):e754\u2013e756. doi:10.1111\/j.1365-2230.2009.03479.x","journal-title":"Clin Exp Dermatol"},{"issue":"9408","key":"3568_CR7","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/S0140-6736(04)15539-6","volume":"363","author":"L Wang","year":"2004","unstructured":"Wang L, Bu D, Yang Y, Chen X, Zhu X (2004) Castleman\u2019s tumours and production of autoantibody in paraneoplastic pemphigus. Lancet 363(9408):525\u2013531. doi:10.1016\/s0140-6736(04)15539-6","journal-title":"Lancet"},{"issue":"2","key":"3568_CR8","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1590\/S1807-59322008000200018","volume":"63","author":"MJ Lopez Meiller","year":"2008","unstructured":"Lopez Meiller MJ, Cavallasca JA, Maliandi Mdel R, Nasswetter GG (2008) Henoch-Schonlein purpura in adults. Clinics (Sao Paulo, Brazil) 63(2):273\u2013276","journal-title":"Clinics (Sao Paulo, Brazil)"},{"issue":"5","key":"3568_CR9","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1093\/rheumatology\/keh544","volume":"44","author":"YH Yang","year":"2005","unstructured":"Yang YH, Hung CF, Hsu CR, Wang LC, Chuang YH, Lin YT, Chiang BL (2005) A nationwide survey on epidemiological characteristics of childhood Henoch-Schonlein purpura in Taiwan. Rheumatology (Oxford) 44(5):618\u2013622. doi:10.1093\/rheumatology\/keh544","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"3568_CR10","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.berh.2004.11.006","volume":"19","author":"RA Watts","year":"2005","unstructured":"Watts RA, Lane S, Scott DG (2005) What is known about the epidemiology of the vasculitides? Best Pract Res Clin Rheumatol 19(2):191\u2013207. doi:10.1016\/j.berh.2004.11.006","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"4","key":"3568_CR11","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1111\/j.1468-3083.2008.03065.x","volume":"23","author":"H Mitsui","year":"2009","unstructured":"Mitsui H, Shibagaki N, Kawamura T, Matsue H, Shimada S (2009) A clinical study of Henoch-Schonlein purpura associated with malignancy. J Eur Acad Dermatol Venereol 23(4):394\u2013401. doi:10.1111\/j.1468-3083.2008.03065.x","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"14","key":"3568_CR12","doi-asserted-by":"publisher","first-page":"2261","DOI":"10.1182\/blood-2013-02-480095","volume":"123","author":"C Mayeur","year":"2014","unstructured":"Mayeur C, Lohmeyer LK, Leyton P, Kao SM, Pappas AE, Kolodziej SA, Spagnolli E, Yu B, Galdos RL, Yu PB, Peterson RT, Bloch DB, Bloch KD, Steinbicker AU (2014) The type I BMP receptor Alk3 is required for the induction of hepatic hepcidin gene expression by interleukin-6. Blood 123(14):2261\u20132268. doi:10.1182\/blood-2013-02-480095","journal-title":"Blood"},{"issue":"18","key":"3568_CR13","doi-asserted-by":"publisher","first-page":"3627","DOI":"10.1182\/blood-2010-03-271791","volume":"116","author":"SN Song","year":"2010","unstructured":"Song SN, Tomosugi N, Kawabata H, Ishikawa T, Nishikawa T, Yoshizaki K (2010) Down-regulation of hepcidin resulting from long-term treatment with an anti-IL-6 receptor antibody (tocilizumab) improves anemia of inflammation in multicentric Castleman disease. Blood 116(18):3627\u20133634. doi:10.1182\/blood-2010-03-271791","journal-title":"Blood"},{"issue":"17","key":"3568_CR14","doi-asserted-by":"publisher","first-page":"4663","DOI":"10.1182\/blood-2011-06-362392","volume":"118","author":"A D'Souza","year":"2011","unstructured":"D'Souza A, Hayman SR, Buadi F, Mauermann M, Lacy MQ, Gertz MA, Kyle RA, Kumar S, Greipp PR, Lust JA, Russell SJ, Zeldenrust S, Dingli D, Witzig TE, Rajkumar SV, Dispenzieri A (2011) The utility of plasma vascular endothelial growth factor levels in the diagnosis and follow-up of patients with poems syndrome. Blood 118(17):4663\u20134665. doi:10.1182\/blood-2011-06-362392","journal-title":"Blood"},{"issue":"11","key":"3568_CR15","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1016\/j.intimp.2008.07.002","volume":"8","author":"Y Uchiyama","year":"2008","unstructured":"Uchiyama Y, Yoshida H, Koike N, Hayakawa N, Sugita A, Nishimura T, Mihara M (2008) Anti-IL-6 receptor antibody increases blood IL-6 level via the blockade of IL-6 clearance, but not via the induction of IL-6 production. Int Immunopharmacol 8(11):1595\u20131601. doi:10.1016\/j.intimp.2008.07.002","journal-title":"Int Immunopharmacol"},{"issue":"7","key":"3568_CR16","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1111\/ced.12089","volume":"38","author":"S Kimura","year":"2013","unstructured":"Kimura S, Takeuchi S, Soma Y, Kawakami T (2013) Raised serum levels of interleukins 6 and 8 and antiphospholipid antibodies in an adult patient with henoch-schonlein purpura. Clin Exp Dermatol 38(7):730\u2013736. doi:10.1111\/ced.12089","journal-title":"Clin Exp Dermatol"},{"issue":"1","key":"3568_CR17","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1046\/j.1365-2133.2000.03597.x","volume":"143","author":"P Rovel-Guitera","year":"2000","unstructured":"Rovel-Guitera P, Diemert MC, Charuel JL, Laporte JL, Musset L, Chosidow O, Piette JC, Frances C (2000) IgA antineutrophil cytoplasmic antibodies in cutaneous vasculitis. Br J Dermatol 143(1):99\u2013103","journal-title":"Br J Dermatol"},{"issue":"5","key":"3568_CR18","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1007\/s10067-004-0910-y","volume":"23","author":"F Ozaltin","year":"2004","unstructured":"Ozaltin F, Bakkaloglu A, Ozen S, Topaloglu R, Kavak U, Kalyoncu M, Besbas N (2004) The significance of IgA class of antineutrophil cytoplasmic antibodies (anca) in childhood Henoch-Schonlein purpura. Clin Rheumatol 23(5):426\u2013429. doi:10.1007\/s10067-004-0910-y","journal-title":"Clin Rheumatol"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-017-3568-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-017-3568-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-017-3568-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T15:33:58Z","timestamp":1659108838000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-017-3568-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,6]]},"references-count":18,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["3568"],"URL":"https:\/\/doi.org\/10.1007\/s10067-017-3568-y","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,6]]},"assertion":[{"value":"10 October 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2017","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2017","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2017","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}